Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled, Blinded Study to Assess the Safety and Efficacy of the Butterfly Medical Prostatic Retraction Device in BPH Patients

NCT05341661 is registered in ClinicalTrials.gov with Butterfly Medical Ltd. as lead sponsor.

NCT NCT05341661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05341661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled, Blinded Study to Assess the Safety and Efficacy of the Butterfly Medical Prostatic Retraction Device in BPH Patients
Lead sponsor
Butterfly Medical Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 7, 2022
Completion date
December 31, 2029
Enrollment
245 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bph (benign prostatic hyperplasia), lower urinary tract symptoms (luts)